Letter in response to: "Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose-the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial"

Trials. 2019 Jun 24;20(1):380. doi: 10.1186/s13063-019-3476-3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acetaminophen*
  • Acetylcysteine
  • Drug Overdose*
  • Edetic Acid / analogs & derivatives
  • Humans
  • Pyridoxal Phosphate / analogs & derivatives
  • Research Design

Substances

  • Acetaminophen
  • Pyridoxal Phosphate
  • Edetic Acid
  • N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
  • Acetylcysteine